When Flu Attacks: Management Strategies to Protect High-Risk Patients

When Flu Attacks: Management Strategies to Protect High-Risk Patients

Release Date: August 31, 2020
Last Reviewed: August 28, 2020
Expiration Date: August 31, 2021
Time to Complete Activity: 1 hour

Julio A. Ramirez, MD

Professor of Medicine
Chief, Division of Infectious Diseases
University of Louisville School of Medicine
Louisville, KY

Charles Vega, MD, FAAFP
Clinical Professor, Family Medicine 
UC Irvine School of Medicine
Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC)
Family Medicine UC Irvine School of Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine 
Orange, CA
This activity is provided by Paradigm Medical Communications, LLC.   

Target Audience
This activity has been designed to address the educational needs of internists and other primary care clinicians, including family physicians, nurse practitioners, and PAs. It may also benefit gynecologists, emergency medicine clinicians, critical care clinicians, urgent care clinicians, pharmacists, and other clinicians who are interested or involved in the care of patients with influenza. 

Statement of Need
After a 20-year period of dormancy, the influenza treatment landscape has been revitalized by the approval of a first-in-class antiviral agent, which recently received a unique expanded indication for the treatment of patients who are at high risk for influenza-related complications. Primary care practitioners (PCPs), who see a large volume of high-risk patients, are uniquely positioned to ensure that such patients receive appropriate and timely care. To do so, they will require enhanced education to bridge gaps related to the diagnosis and treatment of influenza, including recognition of high-risk patients, identification of candidates for antiviral therapy, and the appropriate use of antiviral therapy, in accordance with evolving data and guidelines. 

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Select appropriate candidates for influenza treatment or prophylaxis based on guideline-recommended characteristics, without unnecessary testing
  • Formulate treatment plans for patients with or at risk for influenza and related complications based on the latest evidence

Physician Accreditation Statement
Paradigm Medical Communications, LLC i
s accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. 

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

This activity is supported by an educational grant from Genentech, a member of Roche Group. 

Instructions for  Participation 
To receive a CME certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

There is no fee required for participation in this activity.

Hardware /Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers:
For Desktops (Windows/Mac)
Microsoft Edge 40 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

Adobe Reader
This activity is in Adobe Acrobat PDF format. To view the activity, you will need Adobe Reader. If you do not have Adobe Reader installed on your computer, please visit http://get.adobe.com/reader/ to install a free version of Adobe Reader.

Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.

In accordance with ACCME requirements on disclosure, faculty members and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below. 

Julio A. Ramirez, MD

Consulting Fees: Genentech, Inc.

Charles Vega, MD, FAAFP
Speakers Bureau: Genentech, Inc.

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer, resident/fellow and patient reviewers have no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

This CME activity represents the views and opinions of the individual faculty members, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality.  The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC. 

Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty members, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or a hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com

© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.